Ekso Bionics Holdings Inc. (EKSO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ekso Bionics Holdings Inc. (EKSO:NASDAQ), powered by AI.

Current Price
$11.80
P/E Ratio
-2.4
Market Cap
29M
Sector
Healthcare
What is the Ekso Bionics Holdings Inc. stock price forecast?

Ekso Bionics Holdings Inc. is currently trading at $11.80. View real-time AI analysis on Alpha Lenz.

What is Ekso Bionics Holdings Inc. insider trading activity?

View the latest insider trading data for Ekso Bionics Holdings Inc. on Alpha Lenz.

What is Ekso Bionics Holdings Inc.'s P/E ratio?

Ekso Bionics Holdings Inc.'s P/E ratio is -2.4.

Ekso Bionics Holdings Inc.

NASDAQ · EKSO
$11.80-6.12(-34.15%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Ekso Bionics Holdings Inc.'s future dividend policy...
Alpha Chat Insight

Ekso Bionics Holdings Inc. trades at a P/E of -2.4 (undervalued) with modest ROE of -107.6%.

Ask for details

Company Overview

Ekso Bionics Holdings Inc. is a company that specializes in the development and production of wearable exoskeletons. These innovative robotic devices are primarily designed to augment human strength, endurance, and mobility, offering significant advancements in both medical and industrial sectors. In healthcare, Ekso Bionics focuses on rehabilitation solutions, aiding patients in recovery from spinal cord injuries and other mobility impairments by providing supportive walking assistance. Industrial applications, on the other hand, leverage their exoskeletons to reduce worker fatigue and prevent injuries in physically demanding roles, such as construction or manufacturing. Founded in 2005 and headquartered in Richmond, California, Ekso Bionics is at the forefront of the wearable robotics industry, positioning itself as a pioneer in a niche yet rapidly growing market. The company's technology not only improves quality of life and productivity for individuals but also introduces substantial efficiencies and safety enhancements in various labor-intensive environments. Through its contributions, Ekso Bionics introduces new paradigms in human-machine interfaces and rehabilitation technologies.

CEOMr. Scott G. Davis
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees61

Company Statistics

FY 2025

Profile

$28.63MMarket Cap
$12.80MRevenue
0.00Shares Out
61Employees

Margins

53.48%Gross
-92.03%EBITDA
-104.12%Operating
-91.37%Pre-Tax
-91.37%Net

Valuation

-2.45P/E
3.17P/B
2.24EV/Sales
-2.73EV/EBITDA
-2.39P/FCF

Growth (CAGR)

-0.29%Rev 3Yr
7.58%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-50.02%ROA
-107.62%ROE
-48.70%ROIC

Financial Health

$1.17MCash & Cash Equivalents
$9.91MNet Debt
122.79%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Ekso Bionics Holdings Inc. (ticker: EKSO) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 61 employees. Market cap is $29M.

The current price is $11.8 with a P/E ratio of -2.45x and P/B of 3.17x.

ROE is -107.62% and operating margin is -104.12%. Annual revenue is $13M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Ekso Bionics Holdings Inc. (EKSO) Stock Forecast 2026 $11.80 — Price, Financials & Analyst Targets | Alpha Lenz